Susquehanna International Group, LLP Hoth Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $1.05 $50,688 - $140,059	-133,390 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.52 - $1.3 $63,476 - $158,692	122,071 Added 1078.46%	133,390 $92,000
Q4 2021 Feb 14, 2022	BUY	$0.66 - $1.18 $7,470 - $13,356	11,319 New	11,319 $7,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.02M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.